Merima Herac

896 total citations
23 papers, 454 citations indexed

About

Merima Herac is a scholar working on Oncology, Epidemiology and Hepatology. According to data from OpenAlex, Merima Herac has authored 23 papers receiving a total of 454 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Epidemiology and 7 papers in Hepatology. Recurrent topics in Merima Herac's work include Liver Disease Diagnosis and Treatment (7 papers), Colorectal Cancer Treatments and Studies (4 papers) and Pancreatic and Hepatic Oncology Research (4 papers). Merima Herac is often cited by papers focused on Liver Disease Diagnosis and Treatment (7 papers), Colorectal Cancer Treatments and Studies (4 papers) and Pancreatic and Hepatic Oncology Research (4 papers). Merima Herac collaborates with scholars based in Austria, United States and Switzerland. Merima Herac's co-authors include Michael Trauner, Thomas Reiberger, Georg Oberhuber, Gerald Timelthaler, Judith Stift, Rolf Schulte‐Hermann, Matthias Pinter, Robert Eferl, Nataliya Rohr‐Udilova and Erika Jensen‐Jarolim and has published in prestigious journals such as Hepatology, Scientific Reports and Annals of Oncology.

In The Last Decade

Merima Herac

23 papers receiving 451 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Merima Herac Austria	11	206	147	130	112	89	23	454
Ye Jin Ha South Korea	13	320 1.6×	184 1.3×	154 1.2×	160 1.4×	70 0.8×	27	615
Kylie P. Matchett United Kingdom	8	162 0.8×	155 1.1×	68 0.5×	177 1.6×	37 0.4×	9	432
Simon Wabitsch Germany	14	159 0.8×	230 1.6×	208 1.6×	71 0.6×	115 1.3×	30	522
Stephanie H. Greco United States	8	159 0.8×	85 0.6×	146 1.1×	94 0.8×	32 0.4×	16	497
Yacine Hajji France	4	217 1.1×	319 2.2×	117 0.9×	157 1.4×	134 1.5×	4	606
Renay L. Bauer United States	11	230 1.1×	318 2.2×	93 0.7×	269 2.4×	50 0.6×	12	652
Yadi Liao China	16	137 0.7×	204 1.4×	126 1.0×	250 2.2×	83 0.9×	21	582
Judit Peix Spain	7	133 0.6×	298 2.0×	157 1.2×	307 2.7×	111 1.2×	10	657
Chenzhi Hao China	14	212 1.0×	159 1.1×	101 0.8×	239 2.1×	24 0.3×	19	525
Quentin Bayard France	9	162 0.8×	185 1.3×	105 0.8×	302 2.7×	105 1.2×	13	630

Countries citing papers authored by Merima Herac

Since Specialization

Citations

This map shows the geographic impact of Merima Herac's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Merima Herac with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Merima Herac more than expected).

Fields of papers citing papers by Merima Herac

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Merima Herac. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Merima Herac. The network helps show where Merima Herac may publish in the future.

Co-authorship network of co-authors of Merima Herac

This figure shows the co-authorship network connecting the top 25 collaborators of Merima Herac. A scholar is included among the top collaborators of Merima Herac based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Merima Herac. Merima Herac is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tomasich, Erwin, Jakob Mühlbacher, Katharina Wöran, et al.. (2024). Immune cell distribution and DNA methylation signatures differ between tumor and stroma enriched compartment in pancreatic ductal adenocarcinoma. Translational research. 271. 40–51. 2 indexed citations

Bianconi, Daniela, Elisabeth Fabian, Merima Herac, et al.. (2022). Expression of CD98hc in Pancreatic Cancer and Its Role in Cancer Cell Behavior. Journal of Cancer. 13(7). 2271–2280. 3 indexed citations

Rohr‐Udilova, Nataliya, Kaoru Tsuchiya, Gerald Timelthaler, et al.. (2021). Morphometric Analysis of Mast Cells in Tumor Predicts Recurrence of Hepatocellular Carcinoma After Liver Transplantation. Hepatology Communications. 5(11). 1939–1952. 9 indexed citations

Stift, Judith, Alexandra Gráf, Merima Herac, et al.. (2021). Immune checkpoints and liver resection after neoadjuvant chemotherapy including bevacizumab in patients with microsatellite-stable colorectal liver metastases. HPB. 24(1). 40–46. 3 indexed citations

Fuchs, Claudia, Emmanuel D. Dixon, Veronika Mlitz, et al.. (2021). Hepatocyte‐specific deletion of adipose triglyceride lipase (adipose triglyceride lipase/patatin‐like phospholipase domain containing 2) ameliorates dietary induced steatohepatitis in mice. Hepatology. 75(1). 125–139. 39 indexed citations

Strobl, Johanna, Ram Vinay Pandey, Thomas Krausgruber, et al.. (2020). Anti-Apoptotic Molecule BCL2 Is a Therapeutic Target in Steroid-Refractory Graft-Versus-Host Disease. Journal of Investigative Dermatology. 140(11). 2188–2198. 8 indexed citations

Laengle, Johannes, Irene Kuehrer, Dietmar Pils, et al.. (2020). P08.04 Neoadjuvant chemoradiotherapy with sequential ipilimumab and nivolumab in rectal cancer (CHINOREC): a prospective randomized, open-label, multicenter, phase II clinical trial. A51.1–A51. 2 indexed citations

Bruschi, Francesca Virginia, Matteo Tardelli, Merima Herac, Thierry Claudel, & Michael Trauner. (2020). Metabolic regulation of hepatic PNPLA3 expression and severity of liver fibrosis in patients with NASH. Liver International. 40(5). 1098–1110. 23 indexed citations

Bianconi, Daniela, Merima Herac, Florian Posch, et al.. (2020). Microvascular density assessed by CD31 predicts clinical benefit upon bevacizumab treatment in metastatic colorectal cancer: results of the PassionATE study, a translational prospective Phase II study of capecitabine and irinotecan plus bevacizumab followed by capecitabine and oxaliplatin plus bevacizumab or the reverse sequence in patients in mCRC. Therapeutic Advances in Medical Oncology. 12. 3863543675–3863543675. 13 indexed citations

10.

Katholnig, Karl, Birgit Schütz, Stephanie Deborah Fritsch, et al.. (2019). Inactivation of mTORC2 in macrophages is a signature of colorectal cancer that promotes tumorigenesis. JCI Insight. 4(20). 18 indexed citations

11.

Rohr‐Udilova, Nataliya, Florian Klinglmüller, Rolf Schulte‐Hermann, et al.. (2018). Deviations of the immune cell landscape between healthy liver and hepatocellular carcinoma. Scientific Reports. 8(1). 6220–6220. 130 indexed citations

12.

Bianconi, Daniela, Merima Herac, Daniel Spies, et al.. (2018). SERPINB7 Expression Predicts Poor Pancreatic Cancer Survival Upon Gemcitabine Treatment. Translational Oncology. 12(1). 15–23. 5 indexed citations

13.

Klotz, Sigrid, Christian Matula, Merima Herac, et al.. (2018). Clinical Neuropathology image 6-2018: Metastasis of breast carcinoma to meningioma. Clinical Neuropathology. 37(6). 252–253. 3 indexed citations

14.

Stift, Judith, Alexandra Gráf, Christoph Schwarz, et al.. (2017). Microscopic biliary and perineural invasion and clinical outcome after neoadjuvant bevacizumab-based chemotherapy and liver resection in patients with colorectal liver metastases. European Journal of Surgical Oncology. 44(1). 139–147. 6 indexed citations

15.

Bianconi, Daniela, Gerwin Heller, Daniel Spies, et al.. (2017). Biochemical and genetic predictors of overall survival in patients with metastatic pancreatic cancer treated with capecitabine and nab-paclitaxel. Scientific Reports. 7(1). 4851–4851. 6 indexed citations

16.

Tardelli, Matteo, Francesca Virginia Bruschi, Thierry Claudel, et al.. (2017). AQP3 is regulated by PPARγ and JNK in hepatic stellate cells carrying PNPLA3 I148M. Scientific Reports. 7(1). 14661–14661. 17 indexed citations

17.

Mueller, Michaela, Rui E. Castro, Anders Thorell, et al.. (2017). Ursodeoxycholic acid: Effects on hepatic unfolded protein response, apoptosis and oxidative stress in morbidly obese patients. Liver International. 38(3). 523–531. 30 indexed citations

18.

Bianconi, Daniela, Merima Herac, Andreas Gleiß, et al.. (2016). Functional role of 4F2hc in pancreatic ductal adenocarcinoma. Annals of Oncology. 27. vi14–vi14. 1 indexed citations

19.

Unger, Lukas, Merima Herac, Katharina Staufer, et al.. (2016). The post-transplant course of patients undergoing liver transplantation for nonalcoholic steatohepatitis versus cryptogenic cirrhosis: a retrospective case–control study. European Journal of Gastroenterology & Hepatology. 29(3). 309–316. 12 indexed citations

20.

Herac, Merima, Bruno Niederle, Markus Raderer, et al.. (2016). Expression of somatostatin receptor 2A in medullary thyroid carcinoma is associated with lymph node metastasis. Apmis. 124(10). 839–845. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact